TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 2 | 1 | 4 | 0 | 0 | 0 | 1 | 3 | -4 | 0 |
| S | %wins | 50 | 25 | 75 | 75 | 50 | 75 | 58 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/9/10 17:17 | 12/7/10 | ENDP | Endo Pharmaceuticals Holdings Inc | DE | Health | Drug | Pharmaceutical Preparations | Levin Alan G | PA | O | EVP,CFO | S.d | -599 | 36.04 | 33 | -17 | -59 | 12 | D | 61 | 83 | 67 | 27 | -2 | 2 | 0 | -1 | 1 | 1 | -3 | -1 | 8 | -6 |
5/8/07 15:48 | 5/7/07 | PFE | Pfizer Inc | DE | Health | Drug | Pharmaceutical Preparations | Levin Alan G | NY | O | SVP | S.dm | -4,224 | 27.05 | 33 | -156 | -30 | 360 | D | 6 | 13 | 5 | 3 | 7 | 2 | 2 | 3 | 0 | 1 | -1 | -11 | -12 | -22 |
8/17/06 11:15 | 8/16/06 | PFE | Pfizer Inc | DE | Health | Drug | Pharmaceutical Preparations | Levin Alan G | NY | O | SVP | S.d | -855 | 26.38 | 33 | -32 | -8 | 388 | D | -9 | 7 | 6 | 11 | 14 | 5 | 4 | 4 | 1 | 1 | 5 | -1 | 0 | -7 |
11/14/05 16:08 | 11/11/05 | PFE | Pfizer Inc | DE | Health | Drug | Pharmaceutical Preparations | Levin Alan G | NY | O | SVP | S | -267 | 22.26 | 33 | -12 | -4 | 324 | D | -27 | -16 | -19 | -14 | -11 | 7 | 5 | 2 | -2 | -3 | 0 | 16 | 14 | 21 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |